Councils - Pulmonary Transplantation

SCIENTIFIC COUNCIL ON PULMONARY TRANSPLANTATION
COUNCIL LEADERSHIPQUICK LINKS
CHAIRSUPCOMING EVENTS

PULM TX Council Meeting (Grand Hall B)
Saturday, April 12, 2014
1:05 PM - 1:55 PM
Agenda (pdf)


PULM TX Council Report to the Board (La Jolla AB)
Sunday, April 13, 2014
7:00 AM

Both events will take place at the Manchester Grand Hyatt Hotel, San Diego, CA, USA




HEALTH-RELATED QUALITY OF LIFE (HRQL) RESOURCES

The resources below were developed by the ISHLT Pulmonary Transplantation Council QOL Workforce for clinicians and investigators alike. These resources aim to provide organized, up-to-date summaries of information focused on HRQL in lung transplantation.

HRQL AND LUNG TRANSPLANTATION:
An Annotated Bibliography (PDF)

This annotated bibliography of peer-reviewed publications focused on HRQL in lung transplantation is organized by theme including:

I. Determinants of HRQL
II. Psychosocial factors in HRQL
III. Comparisons of HRQL before and after lung transplantation
IV. Long-term longitudinal studies of HRQL in lung transplant recipients
V. The effect of therapies and interventions on HRQL
VI. Instrument validation and methodology
VII. HRQL as a predictor of clinical outcomes
VIII.  Reviews and Editorials

ISHLT Instruments Used to Measure HRQL in Lung Transplantation (PDF)
This table is an organized list of the HRQL, health status and utility instruments used in studies examining HRQL in lung transplantation.  In addition, links to the original manuscript that introduced each instrument and to the instrument webpage (if available) are provided.

ISHLT Targeted Additional HRQL Resources (PDF)
If you are aware of new articles or resources that are missing, please email jon.singer@ucsf.edu.



PAST COUNCIL MEETING REPORT

2013 PULMTX Council Report to the Board (PDF)



LINKS NEWSLETTER

February 2014
October 2013
May 2013 - PULM TX Council Year in Review
February 2013
November 2011 (PDF)




OTHER LINKS
  • Lung Transplantation Core Competency Curriculum (ISHLT LTx CCC) PDF
  • DCD Guidelines PDF

CHAIR
David Weill, MD
Stanford University Medical Center
Stanford, California, USA
650-724-6795
dweill@stanford.edu

David Weill, MD, is Director of the Center for Advanced Lung Disease, the Adult Cystic Fibrosis Center and Medical Director of the Lung and Heart-Lung Transplant Program at Stanford University Hospitals and Clinics in Stanford, California. Dr. Weill received his medical degree from Tulane University School of Medicine, completed his residency at the University of Texas Southwestern Medical Center, and a fellowship at the University of Colorado School of Medicine. He is board certified in Pulmonary Disease and Creitical Care from the American Board of Internal Medicine.


VICE CHAIR
Michael Mulligan, MD
University of Washington School of Medicine
Seattle, Washington, USA
206-543-3093
msmmd@u.washington.edu

Dr. Michael S. Mulligan is an Endowed Professor in Lung Transplant Research, Chief of the Thoracic Surgery Section, Director of the Lung Transplant Program and Minimally Invasive Surgery Program as well as Director of the Cardiothoracic Research Laboratory at the University of Washington, Seattle, Washington, and one of the only surgeons in the Pacific Northwest who performs pulmonary endarterectomies for chronic pulmonary embolic disease. He organizes national courses in VATS lobectomy and critical care, and lectures internationally on lung transplantation and lung donor management. His laboratory has been consistently funded by the NIH and investigates mechanisms involved in acute lung transplant dysfunction. Dr. Mulligan attended medical school at the University of Connecticut. He completed his general surgery residency at Columbia Presbyterian in Noew York, NY and took time out during his residency for a two-year post doctoral research fellowship in the laboratory of Dr. Peter Ward at the University of Michigan in Ann Arbor, Michigan. He subsequently completed a heart and lung transplant fellowship at the University of Michigan, followed by a cardiothoracic residency at the University of Michigan and finally a general thoracic fellowship, also at the University of Michigan. During that final year in Ann Arbor, he traveled to San Diego to further study the diagnosis and treatment of Chronic Thromboembolic Hypertension.


PAST CHAIR
Lianne G. Singer, MD, FRCPC
Toronto General Hospital
Toronto, Ontario, CANADA
416-340-4996
lianne.singer@uhn.on.ca

Lianne Singer, MD, FRCPC is Medical Director of the Toronto Lung Transplant Program at the University Health Network in Toronto, Ontario, Canada. She is also Associate Professor in the Department of Medicine at the University of Toronto. She completed medical school, Internal Medicine and Respirology training at the University of Toronto. She went on to do a Lung and Heart-Lung Transplantation Fellowship at Stanford University, and advanced training in clinical research at the University of California, San Francisco. Dr. Singer's research interests arise directly from her clinical focus in lung transplantation and include health-related quality of life assessment in advanced lung disease and lung transplantation, telemedicine in lung transplantation, and clinical trials.
COMMITTEE REPRESENTATIVES
2014 ANNUAL MEETING PROGRAM COMMITTEE
Tobias Deuse, MD, PhD
University Heart Center Hamburg
Hamburg, GERMANY
49-152-2281-6664
t.deuse@uke.de

Bio coming soon...




Allan R. Glanville, MD, FRACP
St. Vincent's Hospital
Sydney, AUSTRALIA
61-2-8382-3257
aglanville@stvincents.com.au

Professor Glanville trained in Sydney, Brompton Hospital, London and Stanford University, California. Currently working as a specialist in Lung Transplantation at St. Vincent's Hospital Sydney, he is actively involved with international trials into new immunosuppressive and anti-viral agents. He is Global Principal Investigator for the European and Australian Investigators in Lung Transplantation CeMyLungs trial, and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. He has authored over 140 publications including approaches to antibody mediated rejection, bronchoscopic surveillance, RSV, CMV, Chlamydia and mycobacteria. He is the senior author of the International Guidelines for Lung Transplantation, foundation director of Outcomes Australia and a foundation member of ShareLife Australia.


Denis Hadjiliadis, MD
University of Pennsylvania
Philadelphia, Pennsylvania, USA
215-615-3871
hadjiliadisdenis@hotmail.com

Dr Hadjiliadis is the Paul F Harron Jr Associate Professor of Medicine and the Director of the Adult Cystic Fibrosis Program at the University of Pennsylvania and a member of the Lung Transplant Program at the University of Pennsylvania. He is also the physician leader of the Advanced Lung Disease Research Group. Dr Hadjiliadis completed his medical degree at the University of Toronto, his Internal Medicine residency at the Mayo Clinic and his Pulmonary and Critical Care fellowship at Duke University Medical Center. He subsequently completed an advanced fellowship in Lung Transplantation and Cystic Fibrosis at the University of Toronto and joined its faculty prior to coming to the University of Pennsylvania. His main interests include patient selection and outcomes in lung transplantation, clinical trials in cystic fibrosis and prediction of outcomes and complications in cystic fibrosis. He is board certified by ABIM in Internal Medicine, Pulmonary Disease and Critical Care and by the Royal College of Physicians and Surgeons of Canada in Internal medicine and Respirology.


David Lederer, MD, MS
Columbia University Medical Center
New York, NY, USA
dl427@columbia.edu

Bio coming soon...




Christopher H. Wigfield, MD FRCS(C/Th)
The University of Chicago Medicine & Biological Sciences
Chicago, Illinois, USA
773-702-3554
cwigfield@surgery.bsd.uchicago.edu

Christopher Wigfield, MD, MD, FRCS(C/Th), is Assistant Professor of Cardiothoracic Surgery at The University of Chicago. Dr. Wigfield received his clinical MD at Freie Universitaet Berlin, Germany and an additional Medical Sciences MD from the University of Newcastle upon Tyne, United Kingdom. He completed residencies in General Surgery at Royal Berkshire Hospital and at Freeman Hospital in the UK and went on to complete a fellowship in Cardiothoracic Surgery and Cardiopulmonary Transplantation at the Cardiothoracic Centre in Newcastle upon Tyne, UK. He also completed a Cardiothoracic Surgery fellowship at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin, USA. Dr. Wigfield's clinical and research interests are in thoracic surgery, lung transplantation, robotic assisted surgery and minimally invasive thoracic surgery. He has a dedicated educational portfolio.


Martin R. Zamora, MD
Colorado University Health Science Center
Aurora, Colorado, USA
720-848-2259
marty.zamora@ucdenver.edu

Bio coming soon...
DEVELOPMENT COMMITTEE PULM TX WORKFORCE LEADER
Glen P. Westall, FRACP, PhD
Alfred Hospital
Melbourne, Victoria, AUSTRALIA
61-3-9276-3600
g.westall@alfred.org.au

Bio coming soon...
EDUCATION COMMITTEE PULM TX WORKFORCE LEADER
Kevin M. Chan, MD
Univ of Michigan Health System
Ann Arbor, Michigan, USA
734-936-5201
kevichan@umich.edu

Kevin Chan, MD, is Medical Director of Lung Transplantation and Fellowship Program Director in the Division of Pulmonary and Critical Care Medicine at the University of Michigan in Ann Arbor, MI, USA. Dr. Chan received his medical degree from Wayne State University, completed his internal medicine residency at Rush Presbyterian St. Luke’s Medical Center in Chicago, and fellowship in Pulmonary and Critical Care Medicine at the University Of California Los Angeles Center for the Health Sciences.
I2C2 COMMITTEE PULM TX WORKFORCE LEADER
Lianne G. Singer, MD, FRCPC
Toronto General Hospital
Toronto, Ontario, CANADA
416-340-4996
lianne.singer@uhn.on.ca

See Past Chair for bio...
REGISTRIES & DATABASES COMMITTEE PULM TX WORKFORCE LEADER
Roger D. Yusen, MD, MPH
Washington University School of Medicine
St. Louis, Missouri, USA
314-454-8764
ryusen@dom.wustl.edu

Roger Yusen, MD, MPH, is an Associate Professor of Medicine in the Division of Pulmonary and Critical Care Medicine at Washington University School of Medicine (WUSM) in St. Louis, Missouri, USA. He is a lung transplant pulmonologist and the medical director of the lung volume reduction surgery program at WUSM and Barnes-Jewish Hospital. He focuses his research efforts on technology assessment in pulmonary and transplant medicine.
STANDARDS & GUIDELINES COMMITTEE PULM TX WORKFORCE LEADER
Peter M Hopkins, FRACP
The Prince Charles Hospital
Brisbane, Queensland, AUSTRALIA
61-7-3350-8111
Peter_Hopkins@health.qld.gov.au

Dr Peter Hopkins is the Director of the Quensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. Executive positions are held with the Australian Lung Foundation (PIVOT and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and National Examiners Panel Royal Australian College of Physicians.
LIAISONS & ADDITIONAL WORKFORCES
BOARD OF DIRECTORS LIAISON
Allan R. Glanville, MD, FRACP
St. Vincent's Hospital
Sydney, AUSTRALIA
61-2-8382-3257
aglanville@stvincents.com.au

See above under 'Program Committee' for bio.
BSTR COUNCIL LIAISON
Daniel C. Chambers, MBBS, MD
The Prince Charles Hospital
Brisbane, Queensland, AUSTRALIA
61-7-31394000
Daniel_Chambers@health.qld.gov.au

Dan Chambers, MBBS MRCP FRACP MD, is a Thoracic and Transplant Physician and Head of Research in the Queensland Lung Transplant Service, Prince Charles Hospital, Brisbane, Australia. He is also Associate Professor in the School of Medicine, University of Queensland, and Deputy Chair of the Metropolitan North Human Research and Ethics Committee. He is a member of the Lung Standing Committee for the Transplantation Society of Australia and New Zealand, and the Research Subcommittee for the Thoracic Society of Australia and New Zealand. His main research interests include the pathogenesis of chronic lung allograft dysfunction, early detection of lymphocytic bronchiolitis, lung metagenomics, adult lung disease complicating extreme preterm birth and cell therapy for advanced lung disease.
JUNIOR FACULTY AND TRAINEE COUNCIL LIAISON
Robin Vos, MD, PhD
University Hospital Gasthuisberg
Leuven, BELGIUM
32-16-34-15-48
robin.vos@uz.kuleuven.be

Robin Vos, MD, PhD, is Assistant Professor of Pulmonary Medicine at the Katholieke Universiteit and University Hospital Gasthuisberg, Leuven, Belgium. He obtained his undergraduate degree in Medicine at the Faculty of Medicine, Katholieke Universiteit Leuven, Belgium in 2004, after which he completed his Residency in Internal and Pulmonary Medicine at the University Hospital Gasthuisberg, Leuven, Belgium in 2012. From 2006 until 2010 he performed his PhD fellowship in the lab of Pneumology, Katholieke Universiteit Leuven, Belgium under the supervision of Prof. dr. GM. Verleden. His clinical and research interests include the pathophysiology and treatment of acute and chronic lung allograft rejection.
LINKS COMMUNICATIONS ASSOCIATE EDITOR AND COUNCIL LIAISON
Tereza Martinu, MD
Duke University Medical Center
Durham, North Carolina, USA
919-484-9735
tereza.martinu@duke.edu

Tereza Martinu is an Assistant Professor of Medicine at Duke University and a lung transplant pulmonologist and researcher. She obtained her Medical Degree from McGill University in Montreal, Canada. She subsequently completed training in Internal and then Pulmonary and Critical Care Medicine at Duke University and joined the faculty in 2008. In her clinical time, she cares for lung transplant patients and candidates. In her research time, she studies immunological and cellular mechanisms of post transplant lung injury. Her main focus is on the role of T cell inflammation and epithelial damage on development of bronchiolitis obliterans.
QUALITY OF LIFE WORKFORCE LEADER
Jonathan P Singer, MD MS
UC San Francisco
San Francisco, California, USA
415-235-9921
jon.singer@ucsf.edu

Bio coming soon...

Workforce Members: PDF

Text SizeIncrease Font SizeDecrease Font Size